Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

MicroCap Report: Grenville (V.GRC) performs, Sophiris Bio (SPHS) deflates

Stockhouse Editorial
0 Comments| November 17, 2015

{{labelSign}}  Favorites
{{errorMessage}}

Grenville Strategic Royalty (TSX: V.GRC, Forum) had a good uptick in the markets today after the company announced Q3 2015 financial results with quarterly revenues hitting $4.54 million, a 401% increase compared to the matching 2014 period.

According to the news release, the company noted that Q3 2015 was the seventh consecutive quarter of positive revenue and adjusted EBITDA for that time period was $4.33 million, an increase of 699% over Q3 2014.

The company, one of a handful of investment firms funding industrial and technology companies through revenue-based revenues, also declared a November dividend of $0.00583 per share, or $0.07 on an annualized basis – a 40% increase over the previous monthly dividend. Investors held on tight as traders clamoured to jump on board, sending SP northward. Shares were up 18.33% to $0.71 per share.

Sophiris Bio (NASDAQ: SPHS, Forum) fell considerably on large volume with no news to back up the drop. The last news the company put out was an announcement last week that its Phase 3 BPH Study had successfully met its primary endpoint.

Some traders speculated that the fluctuation in SP was short-timers selling into last week’s news and that blue skies were ahead for the stock that could see valuation go beyond the $5.0 mark based on the potential sales of its newly tested product. Shares were down 21.03% to $1.84 per share.

Select Canadian Small/Micro-cap Advancers (as of 4:00 PM Eastern)
Grenville Strategic Royalty Corp. (V.GRC, Stock Forum) 16.67%
Newalta Corporation (T.NAL, Stock Forum) 9.36%
Horizons BetaPro S&P\/TSX Global Gold Bear Plus ETF (T.HGD, Stock Forum) 9.22%
Canopy Growth Corporation (V.CGC, Stock Forum) 8.61%
High Liner Foods Incorporated (T.HLF, Stock Forum) 6.81%
Select Canadian Small/Micro-cap Decliners (as of 4:00 PM Eastern)
Sophiris Bio Inc (SPHS, Stock Forum) -18.84%
Keek Inc. (V.KEK, Stock Forum) -16.96%
Trevali Mining Corporation (T.TV, Stock Forum) -11.76%
Kirkland Lake Gold Inc. (T.KGI, Stock Forum) -11.28%
Inspira Financial Inc. (V.LND, Stock Forum) -11.11%



{{labelSign}}  Favorites
{{errorMessage}}

Comments

No comments yet. Be first to comment!

Leave a Comment

You must be logged in to be able to post a comment.